use
corticosteroid
treatment
communityacquir
pneumonia
report
almost
year
recent
systemat
analysi
relev
literatur
suggest
corticosteroid
reduc
critic
ill
associ
communityacquir
pneumonia
littl
doubt
prolong
administr
moder
dose
corticosteroid
may
allevi
system
inflammatori
respons
subsequ
organ
dysfunct
sever
infect
whether
favor
effect
morbid
may
translat
better
surviv
qualiti
life
need
address
addit
adequ
power
random
control
trial
previou
issu
critic
care
salluh
colleagu
suggest
evidencebas
recommend
corticosteroid
therapi
communityacquir
pneumonia
corticosteroid
use
adjunct
therapi
sever
infect
roughli
half
centuri
contrast
clinic
practic
research
continu
argu
pro
con
therapeut
approach
era
power
antibiot
likelihood
uncontrol
infect
bacteri
prolifer
becom
less
signific
thu
uncontrol
overwhelm
system
inflamm
like
main
pathogenet
culprit
progress
organ
failur
death
infect
patient
communityacquir
pneumonia
sever
decad
research
host
respons
stress
character
critic
role
intact
hypothalamicpituitaryadren
respons
appropri
tissu
level
corticosteroid
prevent
dissemin
proinflammatori
storm
one
organ
anoth
follow
local
infect
unsurprisingli
communityacquir
pneumonia
blunt
hypothalamicpituitaryadren
axi
clearli
associ
worsen
patient
condit
broadli
concept
critic
illnessrel
corticosteroid
insuffici
defin
inadequ
intracellular
glucocorticoid
antiinflammatori
activ
sever
patient
ill
becom
readili
accept
endocrinologist
intensivist
ampl
evid
shown
prolong
treatment
moder
dose
corticosteroid
improv
intracellular
downregul
inflammatori
cytokin
transcript
acceler
resolut
critic
ill
new
advanc
understand
molecular
mechan
corticosteroid
action
implic
sepsi
recent
review
addit
recent
literatur
provid
strong
experiment
support
use
prolong
corticosteroid
treatment
pneumonia
previou
issu
critic
care
salluh
colleagu
review
four
studi
investig
corticosteroid
treatment
communityacquir
pneumonia
includ
three
random
control
trial
one
retrospect
studi
increas
surviv
report
two
studi
investig
treatment
durat
equal
greater
day
lack
surviv
benefit
report
short
durat
treatment
author
found
evid
rather
favor
benefitrisk
profil
improv
physiolog
clinic
outcom
evid
increas
harm
use
corticosteroid
treatment
sepsi
date
back
earli
favor
effect
hydrocortison
mgday
oral
report
patient
pneumococc
pneumonia
addit
studi
subgroup
analys
patient
communityacquir
pneumonia
recent
provid
two
random
trial
commentari
corticosteroid
communityacquir
pneumonia
time
act
djillali
annan
g
umberto
meduri
investig
prolong
corticosteroid
treatment
patient
septic
shock
acut
respiratori
distress
syndrom
ard
septic
shock
patient
communityacquir
pneumonia
corticosteroidtr
patient
n
improv
surviv
hazard
ratio
confid
interv
ard
trial
patient
sever
communityacquir
pneumonia
treat
patient
nonstatist
signific
increas
rate
extub
day
versu
p
reduct
median
durat
mechan
ventil
versu
day
p
creactiv
protein
level
plasma
versu
mgl
p
hospit
mortal
versu
p
also
import
rememb
prolong
corticosteroid
treatment
alreadi
proven
effect
decreas
mortal
two
form
lifethreaten
pneumonia
pneumocysti
jiroveci
pneumonia
sever
acut
respiratori
syndrom
theori
corticosteroid
may
favor
onset
gastroduoden
bleed
superinfect
metabol
disord
muscl
weak
recent
systemat
review
use
corticosteroid
sever
sepsi
septic
shock
howev
fail
show
evid
increas
risk
bleed
superinfect
neuromuscular
weak
wherea
hypernatremia
hyperglycaemia
occur
frequent
treat
patient
annan
person
commun
import
physician
implement
prevent
measur
perform
daili
screen
possibl
complic
specif
surveil
potenti
site
superinfect
control
blood
glucos
serum
sodium
level
systemat
perform
clinic
practic
favor
benefitrisk
profil
moder
dose
corticosteroid
reason
support
use
sever
case
communityacquir
pneumonia
high
predict
mortal
patient
shock
respiratori
failur
progress
organ
dysfunct
despit
receiv
appropri
antibiot
conclus
answer
recommend
howev
obtain
addit
research
pneumonia
lead
caus
sepsisassoci
death
world
littl
reduct
mortal
achiev
last
year
respons
scientif
commun
govern
agenc
promptli
set
larg
intern
random
control
trial
definit
character
benefit
potenti
harm
corticosteroid
given
patient
communityacquir
pneumonia
public
consensu
among
expert
design
futur
random
trial
facilit
progress
import
research
